Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

USA Mitchell Cancer Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

USA Mitchell Cancer Institute brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 501. Its research centres on myeloma treatment and antibody therapy side effects. It covers a mezigdomide dose study in relapsed myeloma and macrophage activity behind cytokine release.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Cancer center of the University of South Alabama in Mobile.
Booth
Exhibiting at Booth 501
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at USA Mitchell Cancer Institute

Tell us what you sell and we’ll find the people at USA Mitchell Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction